Digital mental health group XenZone has listed on the small-cap AIM exchange, raising £16m. Its CEO tells HBI that the company is targeting entry to the US and Europe. It has also rebranded as Kooth, its main brand name.
Global lab company Sonic Healthcare is reportedly reviewing its Irish operations as litigation claims related to Ireland’s CervicalCheck scandal mount and the subsidiary posts falling profits. HBI examines the role of the private sector in the screening scandal and talks to a solicitor representing half of the plaintiffs. Documents seen by HBI show evidence that slides were up to 7x more likely to be misread when outsourced.
The CEO of City & County Healthcare, the second-largest domiciliary care provider in the UK with 2019 revenue of £ 236m, tells HBI how the company is navigating the COVID-19 crisis and what prospects are now like for a sale.
Sweden's largest telehealth player KRY will be reimbursed in Germany after it received the necessary security accreditation. Meanwhile, Docly, the spin-off from Sweden's once largest player Min Doktor, has just withdrawn its healthcare services from its only international market following slow growth.
HBI talks to Stefan Nilsson, CEO of Colosseum Dental Group, the Swiss-based pan-European chain with a presence in Finland, Norway, Sweden, Switzerland, Italy, Denmark, Germany and the UK, about how it has weathered COVID, and its plans going forward as we all adapt to the new normal.
As we begin to understand the true impact of COVID-19, large disparities of outcome are emerging between countries. HBI speaks to operators and consultants across Europe to investigate how markets have been hit.
NHS England's exhaustive block-buying deal with the country's private hospitals will soon be replaced by a more local arrangement to help clear COVID-related backlogs of elective procedures, while smaller players are jostling to attack growing waiting lists for diagnostics. An advisor says the private sector is cutting corners when it comes to controlling COVID-19.
HBI hears UK hospital and outpatient operators are taking a long hard look at their public/for-profit payor split as they continue to count the financial effect of COVID and look to the future.
Headspace started a decade ago as a meditation app founded by a Buddhist monk. It is now one of the world's most successful consumer B2C businesses with 65m downloads, 2m paying subscribers and north of $50m revenue. HBI speaks to Pablo Pantaleoni who is leading the early stages of clinical trials for digital therapeutics (DTx) through its medical subsidiary, Headspace Health.
Outpatient activity all but came to a standstill as the COVID crisis tightened its grip. A panel of experts comprising Richard Banks, Chief Strategy Officer at international fertility player Virtus Health, Martin Bundschu, Director at Germany-based optical specialist Smile Eyes, former Colosseum Dental CEO Tomas Aubell, and L.E.K. Consulting's global co-head of healthcare Ben Faircloth joined an HBI-365 audience last week to discuss what a good outpatient clinic post-COVID might look like, and how markets have been affected.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.